Acadia Pharmaceuticals buy BMO Capital Markets
Start price
19.05.25
/
50%
€19.41
Target price
19.05.26
€25.05
Performance (%)
-9.74%
End price
20.05.26
€17.52
Summary
This prediction ended on 20.05.26 with a price of €17.52. With a performance of -9.74%, the BUY prediction by BMO_Capital_Markets finished with a loss. BMO_Capital_Markets has a follow-up prediction for Acadia Pharmaceuticals where he still thinks Acadia Pharmaceuticals is a Buy. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Acadia Pharmaceuticals | 2.466% | 2.466% | 17.089% |
| iShares Core DAX® | 2.992% | 3.220% | 4.271% |
| iShares Nasdaq 100 | -1.584% | -3.172% | 24.749% |
| iShares Nikkei 225® | -2.254% | -9.924% | 43.518% |
| iShares S&P 500 | -0.009% | 1.641% | 20.967% |
Comments by BMO_Capital_Markets for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target raised by analysts at BMO Capital Markets from $24.00 to $28.00. They now have an "outperform" rating on the stock.
Ratings data for ACAD provided by MarketBeat
In the thread Trading Acadia Pharmaceuticals
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten
Current prediction by BMO_Capital_Markets for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€22.30
21.07.26
21.07.26
€31.55
21.07.27
21.07.27
2.47%
28.07.26
28.07.26
Stopped prediction by BMO_Capital_Markets for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€15.27
27.06.24
27.06.24
€28.91
27.06.25
27.06.25
23.25%
28.06.25
28.06.25